Author Details

Феденко, Александр Александрович

Issue	Section	Title	File
Vol 19, No 3 (2017)	Articles	The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation	(Rus) () () () () () () ()
Vol 22, No 4 (2020)	CLINICAL ONCOLOGY	Differentiated thyroid cancer	(Rus)
Vol 23, No 2 (2021)	CLINICAL ONCOLOGY	Prostate cancer	(Rus)
Vol 23, No 3 (2021)	CLINICAL ONCOLOGY	Malignant neoplasm of the bronchi and lung: Russian clinical guidelines	(Rus)
Vol 23, No 4 (2021)	CLINICAL ONCOLOGY	Gastric cancer: Russian clinical guidelines	(Rus)
Vol 24, No 2 (2022)	CLINICAL ONCOLOGY	Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report	(Rus)
Vol 24, No 3 (2022)	CLINICAL ONCOLOGY	Malignant neoplasm of the bronchi and lung: Russian clinical guidelines	(Rus)
Vol 24, No 4 (2022)	CLINICAL ONCOLOGY	Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study	(Rus)
Vol 26, No 1 (2024)	Articles	Final data on the eﬃcacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world eﬃcacy of prolgolimab in patients with metastatic melanoma in Russia	(Rus)
Vol 26, No 2 (2024)	Articles	Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study	(Rus)
Vol 27, No 3 (2025)	Articles	Comparative efficacy and safety of prolgolimab + nurulimab and nivolumab + ipilimumab in the first-line therapy of metastatic or unresectable melanoma: A systematic review and matching-adjusted indirect comparison	(Rus)

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register